Bill > A2632

Introduced Session

This bill requires the Department of Health (department) to establish Alzheimer's disease public awareness campaign. Under the bill, the Commissioner of Health (commissioner), subject to available funds, is to establish an Alzheimer's disease public awareness and education program (program). The purpose of the program is to promote public awareness of Alzheimer's disease and the value of early detection and possible treatments, including the benefits and risks of those treatments. The department may accept for that purpose any grant of monies, services, or property from the federal government, an organization, or a medical school. The program is to include the following: (1) development of a public campaign to promote Alzheimer's disease awareness and education, including, but not limited to, the subjects outlined in the bill; (2) development of educational materials to be made available through local boards of health, physicians, hospitals, and clinics; (3) development of educational programs for judicial staff, police officers, fire fighters, and social services and emergency medical service providers, to assist them in recognizing the symptoms of Alzheimer's disease and understanding how to respond to the needs of persons with the disease in the course of performing their duties; (4) development and maintenance of a list of current providers of services for the diagnosis and treatment of Alzheimer's disease. Dissemination of the list is to be accompanied by a description of diagnostic procedures and a statement about the current status of Alzheimer's disease research and treatment. The statement is to indicate that the department does not endorse specific Alzheimer's disease centers in this State; and (5) continuation of New Jersey's Behavioral Risk Factor Survey. The bill provides that the department, in consultation with the Greater New Jersey Chapter of the Alzheimer's Association, is to prepare and make available on the department's Internet website in English and Spanish, and in a manner that is easily understandable by the general public, information about the symptoms and treatment of Alzheimer's disease and any other information that the commissioner deems necessary.

AI Summary

Committee Categories

Annette Chaparro (D)*,  Raj Mukherji (D)*,  Valerie Vainieri Huttle (D)*,  Daniel Benson (D),  Clinton Calabrese (D),  Ralph Caputo (D),  Linda Carter (D),  John Catalano (R),  Nicholas Chiaravalloti (D),  Herbert Conaway (D),  Ronald Dancer (R),  Wayne DeAngelo (D),  John DiMaio (R),  Thomas Giblin (D),  Mila Jasey (D),  Gordon Johnson (D),  Robert Karabinchak (D),  Greg McGuckin (R),  Angela Mcknight (D),  Bill Moen (D),  Annette Quijano (D),  Verlina Reynolds-Jackson (D),  Britnee Timberlake (D), 

Reported out of Assembly Comm. with Amendments, 2nd Reading (on 12/06/2021)

Official Document